These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 25230688)
1. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy. Zhou SW; Zhang M; Zhu M Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688 [TBL] [Abstract][Full Text] [Related]
2. [Sodium nitrite reduces lipid accumulation in steatotic cells by enhancing autophagy]. Zhang YJ; Zheng NR; Liu B; Ji AL; Li YZ; Huangfu CS Yao Xue Xue Bao; 2015 Aug; 50(8):1000-7. PubMed ID: 26669000 [TBL] [Abstract][Full Text] [Related]
3. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy]. Shi YM; Fu ZH; Zhu CS; Li XP Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951 [TBL] [Abstract][Full Text] [Related]
4. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. Chu JH; Wang H; Ye Y; Chan PK; Pan SY; Fong WF; Yu ZL World J Gastroenterol; 2011 May; 17(19):2379-88. PubMed ID: 21633637 [TBL] [Abstract][Full Text] [Related]
6. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway. He Q; Sha S; Sun L; Zhang J; Dong M Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776 [TBL] [Abstract][Full Text] [Related]
7. [Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve non-alcoholic fatty liver]. Zhang Q; Liu Q; Niu CY Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):456-461. PubMed ID: 34107584 [No Abstract] [Full Text] [Related]
8. Liraglutide ameliorates hepatic steatosis via retinoic acid receptor-related orphan receptor α-mediated autophagy pathway. Yu X; Bian X; Zhang H; Yang S; Cui D; Su Z IUBMB Life; 2023 Oct; 75(10):856-867. PubMed ID: 37310057 [TBL] [Abstract][Full Text] [Related]
9. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells. Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863 [TBL] [Abstract][Full Text] [Related]
10. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. Sharma S; Mells JE; Fu PP; Saxena NK; Anania FA PLoS One; 2011; 6(9):e25269. PubMed ID: 21957486 [TBL] [Abstract][Full Text] [Related]
11. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells. Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193 [TBL] [Abstract][Full Text] [Related]
12. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ. Yang M; Chen Z; Xiang S; Xia F; Tang W; Yao X; Zhou B BMC Complement Med Ther; 2020 Dec; 20(1):377. PubMed ID: 33308192 [TBL] [Abstract][Full Text] [Related]
13. Xiaoyao San attenuates hepatic steatosis through estrogen receptor α pathway in ovariectomized ApoE-/- mice. Hu T; Wei M; Hong G; Qi T; Xiang Y; Yang Y; Yi Y J Ethnopharmacol; 2022 Jan; 282():114612. PubMed ID: 34496266 [TBL] [Abstract][Full Text] [Related]
14. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway. Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy impairs free fatty acid-induced excessive lipid accumulation in hepatocellular carcinoma and hepatic cells. Chen X; Liu H; Chen K; Guo Y; Mo T; Gao T J Biosci; 2022; 47():. PubMed ID: 36210729 [TBL] [Abstract][Full Text] [Related]
16. Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635 [No Abstract] [Full Text] [Related]
17. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. Zheng L; Lv GC; Sheng J; Yang YD J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876 [TBL] [Abstract][Full Text] [Related]
18. ERp57 is up-regulated in free fatty acids-induced steatotic L-02 cells and human nonalcoholic fatty livers. Wang H; Chan PK; Pan SY; Kwon KH; Ye Y; Chu JH; Fong WF; Tsui WM; Yu ZL J Cell Biochem; 2010 Aug; 110(6):1447-56. PubMed ID: 20506389 [TBL] [Abstract][Full Text] [Related]
19. Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells. Wang JW; Wan XY; Zhu HT; Lu C; Yu WL; Yu CH; Shen Z; Li YM PLoS One; 2014; 9(4):e96124. PubMed ID: 24788149 [TBL] [Abstract][Full Text] [Related]
20. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway. Xu N; Luo H; Li M; Wu J; Wu X; Chen L; Gan Y; Guan F; Li M; Su Z; Chen J; Liu Y Biomed Pharmacother; 2021 Feb; 134():111104. PubMed ID: 33341045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]